Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors
US8198298B2 · kind B2 · utility
24Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2011 |
| Grant date | Jun 12, 2012 |
| Priority date | — |
| Expiry date | Apr 9, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.